Global Tuberculosis (TB) Diagnostics Competitive Landscape Professional Research Report 2025
Market Overview
According to DIResearch's in-depth investigation and research, the global Tuberculosis (TB) Diagnostics market size will reach 3,229.33 Million USD in 2025 and is projected to reach 4,444.96 Million USD by 2032, with a CAGR of 4.67% (2025-2032). Notably, the China Tuberculosis (TB) Diagnostics market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Tuberculosis (TB) diagnostics encompass a range of tests and methods aimed at identifying and confirming the presence of tuberculosis infection in individuals. One of the primary diagnostic tools is the tuberculin skin test (TST) or Mantoux test, which assesses the immune response to the tuberculosis bacterium. Additionally, molecular tests, such as nucleic acid amplification tests (NAATs) and polymerase chain reaction (PCR) assays, allow for the detection of Mycobacterium tuberculosis DNA in clinical samples. Chest X-rays are often employed to visualize lung abnormalities associated with active TB. More recently, interferon-gamma release assays (IGRAs) have been developed to measure the immune response to specific TB antigens. Culturing of samples, typically sputum, can definitively confirm the presence of the bacteria. TB diagnostics play a critical role in early detection, treatment initiation, and the overall management of tuberculosis, a contagious infectious disease that poses significant global health challenges.
The major global suppliers of Tuberculosis (TB) Diagnostics include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, Hologic, Qiagen, BioMerieux, Hain Lifescience, Oxford Immunotec, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Tuberculosis (TB) Diagnostics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Tuberculosis (TB) Diagnostics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Tuberculosis (TB) Diagnostics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Tuberculosis (TB) Diagnostics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Tuberculosis (TB) Diagnostics Include:
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec
Tuberculosis (TB) Diagnostics Product Segment Include:
Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others
Tuberculosis (TB) Diagnostics Product Application Include:
Diagnostic Laboratories
Hospitals
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Tuberculosis (TB) Diagnostics Industry PESTEL Analysis
Chapter 3: Global Tuberculosis (TB) Diagnostics Industry Porter’s Five Forces Analysis
Chapter 4: Global Tuberculosis (TB) Diagnostics Major Regional Market Size and Forecast Analysis
Chapter 5: Global Tuberculosis (TB) Diagnostics Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Tuberculosis (TB) Diagnostics Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Tuberculosis (TB) Diagnostics market size will reach 3,229.33 Million USD in 2025 and is projected to reach 4,444.96 Million USD by 2032, with a CAGR of 4.67% (2025-2032). Notably, the China Tuberculosis (TB) Diagnostics market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Tuberculosis (TB) diagnostics encompass a range of tests and methods aimed at identifying and confirming the presence of tuberculosis infection in individuals. One of the primary diagnostic tools is the tuberculin skin test (TST) or Mantoux test, which assesses the immune response to the tuberculosis bacterium. Additionally, molecular tests, such as nucleic acid amplification tests (NAATs) and polymerase chain reaction (PCR) assays, allow for the detection of Mycobacterium tuberculosis DNA in clinical samples. Chest X-rays are often employed to visualize lung abnormalities associated with active TB. More recently, interferon-gamma release assays (IGRAs) have been developed to measure the immune response to specific TB antigens. Culturing of samples, typically sputum, can definitively confirm the presence of the bacteria. TB diagnostics play a critical role in early detection, treatment initiation, and the overall management of tuberculosis, a contagious infectious disease that poses significant global health challenges.
The major global suppliers of Tuberculosis (TB) Diagnostics include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, Hologic, Qiagen, BioMerieux, Hain Lifescience, Oxford Immunotec, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Tuberculosis (TB) Diagnostics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Tuberculosis (TB) Diagnostics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Tuberculosis (TB) Diagnostics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Tuberculosis (TB) Diagnostics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Tuberculosis (TB) Diagnostics Include:
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec
Tuberculosis (TB) Diagnostics Product Segment Include:
Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others
Tuberculosis (TB) Diagnostics Product Application Include:
Diagnostic Laboratories
Hospitals
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Tuberculosis (TB) Diagnostics Industry PESTEL Analysis
Chapter 3: Global Tuberculosis (TB) Diagnostics Industry Porter’s Five Forces Analysis
Chapter 4: Global Tuberculosis (TB) Diagnostics Major Regional Market Size and Forecast Analysis
Chapter 5: Global Tuberculosis (TB) Diagnostics Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Tuberculosis (TB) Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Tuberculosis (TB) Diagnostics Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
1 TUBERCULOSIS (TB) DIAGNOSTICS MARKET OVERVIEW
1.1 Product Definition and Statistica Sclope
1.2 Tuberculosis (TB) Diagnostics Product by Type
1.2.1 Culture-Based Diagnostics
1.2.2 Sputum Smear Microscopy
1.2.3 Rapid Molecular Diagnostics
1.2.4 Others
1.3 Tuberculosis (TB) Diagnostics Product by Application
1.3.1 Diagnostic Laboratories
1.3.2 Hospitals
1.4 Global Tuberculosis (TB) Diagnostics Market Size Analysis (2020-2032)
1.5 Tuberculosis (TB) Diagnostics Market Development Status and Trends
1.5.1 Tuberculosis (TB) Diagnostics Industry Development Status Analysis
1.5.2 Tuberculosis (TB) Diagnostics Industry Development Trends Analysis
2 TUBERCULOSIS (TB) DIAGNOSTICS MARKET PESTEL ANALYSIS
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 TUBERCULOSIS (TB) DIAGNOSTICS MARKET PORTER'S FIVE FORCES ANALYSIS
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 GLOBAL TUBERCULOSIS (TB) DIAGNOSTICS MARKET ANALYSIS BY REGIONS
4.1 Global Tuberculosis (TB) Diagnostics Overall Market: 2024 VS 2025 VS 2032
4.2 Global Tuberculosis (TB) Diagnostics Revenue and Forecast Analysis (2020-2032)
4.2.1 Global Tuberculosis (TB) Diagnostics Revenue and Market Share by Region (2020-2025)
4.2.2 Global Tuberculosis (TB) Diagnostics Revenue and Market Share Forecast by Region (2026-2032)
5 GLOBAL TUBERCULOSIS (TB) DIAGNOSTICS MARKET SIZE BY TYPE AND APPLICATION
5.1 Global Tuberculosis (TB) Diagnostics Market Size by Type (2020-2032)
5.2 Global Tuberculosis (TB) Diagnostics Market Size by Application (2020-2032)
6 NORTH AMERICA
6.1 North America Tuberculosis (TB) Diagnostics Market Size and Growth Rate Analysis (2020-2032)
6.2 North America Key Suppliers Analysis
6.3 North America Tuberculosis (TB) Diagnostics Market Size by Type
6.4 North America Tuberculosis (TB) Diagnostics Market Size by Application
6.5 North America Tuberculosis (TB) Diagnostics Market Size by Country
6.5.1 US
6.5.2 Canada
7 EUROPE
7.1 Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate Analysis (2020-2032)
7.2 Europe Key Suppliers Analysis
7.3 Europe Tuberculosis (TB) Diagnostics Market Size by Type
7.4 Europe Tuberculosis (TB) Diagnostics Market Size by Application
7.5 Europe Tuberculosis (TB) Diagnostics Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 CHINA
8.1 China Tuberculosis (TB) Diagnostics Market Size and Growth Rate Analysis (2020-2032)
8.2 China Key Suppliers Analysis
8.3 China Tuberculosis (TB) Diagnostics Market Size by Type
8.4 China Tuberculosis (TB) Diagnostics Market Size by Application
9 APAC (EXCL. CHINA)
9.1 APAC (excl. China) Tuberculosis (TB) Diagnostics Market Size and Growth Rate Analysis (2020-2032)
9.2 APAC (excl. China) Key Suppliers Analysis
9.3 APAC (excl. China) Tuberculosis (TB) Diagnostics Market Size by Type
9.4 APAC (excl. China) Tuberculosis (TB) Diagnostics Market Size by Application
9.5 APAC (excl. China) Tuberculosis (TB) Diagnostics Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Southeast Asia
10 LATIN AMERICA
10.1 Latin America Tuberculosis (TB) Diagnostics Market Size and Growth Rate Analysis (2020-2032)
10.2 Latin America Key Suppliers Analysis
10.3 Latin America Tuberculosis (TB) Diagnostics Market Size by Type
10.4 Latin America Tuberculosis (TB) Diagnostics Market Size by Application
10.5 Latin America Tuberculosis (TB) Diagnostics Market Size by Country
10.5.1 Mexico
10.5.2 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size and Growth Rate Analysis (2020-2032)
11.2 Middle East & Africa Key Suppliers Analysis
11.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Type
11.4 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Application
11.5 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 COMPETITION BY SUPPLIERS
12.1 Global Tuberculosis (TB) Diagnostics Market Revenue by Key Suppliers (2021-2025)
12.2 Tuberculosis (TB) Diagnostics Competitive Landscape Analysis and Market Dynamic
12.2.1 Tuberculosis (TB) Diagnostics Competitive Landscape Analysis
12.2.2 Global Key Suppliers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 KEY COMPANIES ANALYSIS
13.1 Danaher
13.1.1 Danaher Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Danaher Tuberculosis (TB) Diagnostics Product Portfolio
13.1.3 Danaher Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.2 Roche
13.2.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Roche Tuberculosis (TB) Diagnostics Product Portfolio
13.2.3 Roche Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.3 Thermo Fisher Scientific
13.3.1 Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Portfolio
13.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.4 BD
13.4.1 BD Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 BD Tuberculosis (TB) Diagnostics Product Portfolio
13.4.3 BD Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.5 Abbott
13.5.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Abbott Tuberculosis (TB) Diagnostics Product Portfolio
13.5.3 Abbott Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.6 Hologic
13.6.1 Hologic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Hologic Tuberculosis (TB) Diagnostics Product Portfolio
13.6.3 Hologic Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.7 Qiagen
13.7.1 Qiagen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 Qiagen Tuberculosis (TB) Diagnostics Product Portfolio
13.7.3 Qiagen Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.8 BioMerieux
13.8.1 BioMerieux Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 BioMerieux Tuberculosis (TB) Diagnostics Product Portfolio
13.8.3 BioMerieux Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.9 Hain Lifescience
13.9.1 Hain Lifescience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Hain Lifescience Tuberculosis (TB) Diagnostics Product Portfolio
13.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.10 Oxford Immunotec
13.10.1 Oxford Immunotec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 Oxford Immunotec Tuberculosis (TB) Diagnostics Product Portfolio
13.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
14 INDUSTRY CHAIN ANALYSIS
14.1 Tuberculosis (TB) Diagnostics Industry Chain Analysis
14.2 Tuberculosis (TB) Diagnostics Typical Downstream Customers
14.3 Tuberculosis (TB) Diagnostics Sales Channel Analysis
15 RESEARCH FINDINGS AND CONCLUSION
16 METHODOLOGY AND DATA SOURCE
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer
1.1 Product Definition and Statistica Sclope
1.2 Tuberculosis (TB) Diagnostics Product by Type
1.2.1 Culture-Based Diagnostics
1.2.2 Sputum Smear Microscopy
1.2.3 Rapid Molecular Diagnostics
1.2.4 Others
1.3 Tuberculosis (TB) Diagnostics Product by Application
1.3.1 Diagnostic Laboratories
1.3.2 Hospitals
1.4 Global Tuberculosis (TB) Diagnostics Market Size Analysis (2020-2032)
1.5 Tuberculosis (TB) Diagnostics Market Development Status and Trends
1.5.1 Tuberculosis (TB) Diagnostics Industry Development Status Analysis
1.5.2 Tuberculosis (TB) Diagnostics Industry Development Trends Analysis
2 TUBERCULOSIS (TB) DIAGNOSTICS MARKET PESTEL ANALYSIS
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 TUBERCULOSIS (TB) DIAGNOSTICS MARKET PORTER'S FIVE FORCES ANALYSIS
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 GLOBAL TUBERCULOSIS (TB) DIAGNOSTICS MARKET ANALYSIS BY REGIONS
4.1 Global Tuberculosis (TB) Diagnostics Overall Market: 2024 VS 2025 VS 2032
4.2 Global Tuberculosis (TB) Diagnostics Revenue and Forecast Analysis (2020-2032)
4.2.1 Global Tuberculosis (TB) Diagnostics Revenue and Market Share by Region (2020-2025)
4.2.2 Global Tuberculosis (TB) Diagnostics Revenue and Market Share Forecast by Region (2026-2032)
5 GLOBAL TUBERCULOSIS (TB) DIAGNOSTICS MARKET SIZE BY TYPE AND APPLICATION
5.1 Global Tuberculosis (TB) Diagnostics Market Size by Type (2020-2032)
5.2 Global Tuberculosis (TB) Diagnostics Market Size by Application (2020-2032)
6 NORTH AMERICA
6.1 North America Tuberculosis (TB) Diagnostics Market Size and Growth Rate Analysis (2020-2032)
6.2 North America Key Suppliers Analysis
6.3 North America Tuberculosis (TB) Diagnostics Market Size by Type
6.4 North America Tuberculosis (TB) Diagnostics Market Size by Application
6.5 North America Tuberculosis (TB) Diagnostics Market Size by Country
6.5.1 US
6.5.2 Canada
7 EUROPE
7.1 Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate Analysis (2020-2032)
7.2 Europe Key Suppliers Analysis
7.3 Europe Tuberculosis (TB) Diagnostics Market Size by Type
7.4 Europe Tuberculosis (TB) Diagnostics Market Size by Application
7.5 Europe Tuberculosis (TB) Diagnostics Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 CHINA
8.1 China Tuberculosis (TB) Diagnostics Market Size and Growth Rate Analysis (2020-2032)
8.2 China Key Suppliers Analysis
8.3 China Tuberculosis (TB) Diagnostics Market Size by Type
8.4 China Tuberculosis (TB) Diagnostics Market Size by Application
9 APAC (EXCL. CHINA)
9.1 APAC (excl. China) Tuberculosis (TB) Diagnostics Market Size and Growth Rate Analysis (2020-2032)
9.2 APAC (excl. China) Key Suppliers Analysis
9.3 APAC (excl. China) Tuberculosis (TB) Diagnostics Market Size by Type
9.4 APAC (excl. China) Tuberculosis (TB) Diagnostics Market Size by Application
9.5 APAC (excl. China) Tuberculosis (TB) Diagnostics Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Southeast Asia
10 LATIN AMERICA
10.1 Latin America Tuberculosis (TB) Diagnostics Market Size and Growth Rate Analysis (2020-2032)
10.2 Latin America Key Suppliers Analysis
10.3 Latin America Tuberculosis (TB) Diagnostics Market Size by Type
10.4 Latin America Tuberculosis (TB) Diagnostics Market Size by Application
10.5 Latin America Tuberculosis (TB) Diagnostics Market Size by Country
10.5.1 Mexico
10.5.2 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size and Growth Rate Analysis (2020-2032)
11.2 Middle East & Africa Key Suppliers Analysis
11.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Type
11.4 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Application
11.5 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 COMPETITION BY SUPPLIERS
12.1 Global Tuberculosis (TB) Diagnostics Market Revenue by Key Suppliers (2021-2025)
12.2 Tuberculosis (TB) Diagnostics Competitive Landscape Analysis and Market Dynamic
12.2.1 Tuberculosis (TB) Diagnostics Competitive Landscape Analysis
12.2.2 Global Key Suppliers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 KEY COMPANIES ANALYSIS
13.1 Danaher
13.1.1 Danaher Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Danaher Tuberculosis (TB) Diagnostics Product Portfolio
13.1.3 Danaher Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.2 Roche
13.2.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Roche Tuberculosis (TB) Diagnostics Product Portfolio
13.2.3 Roche Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.3 Thermo Fisher Scientific
13.3.1 Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Portfolio
13.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.4 BD
13.4.1 BD Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 BD Tuberculosis (TB) Diagnostics Product Portfolio
13.4.3 BD Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.5 Abbott
13.5.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Abbott Tuberculosis (TB) Diagnostics Product Portfolio
13.5.3 Abbott Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.6 Hologic
13.6.1 Hologic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Hologic Tuberculosis (TB) Diagnostics Product Portfolio
13.6.3 Hologic Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.7 Qiagen
13.7.1 Qiagen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 Qiagen Tuberculosis (TB) Diagnostics Product Portfolio
13.7.3 Qiagen Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.8 BioMerieux
13.8.1 BioMerieux Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 BioMerieux Tuberculosis (TB) Diagnostics Product Portfolio
13.8.3 BioMerieux Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.9 Hain Lifescience
13.9.1 Hain Lifescience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Hain Lifescience Tuberculosis (TB) Diagnostics Product Portfolio
13.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.10 Oxford Immunotec
13.10.1 Oxford Immunotec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 Oxford Immunotec Tuberculosis (TB) Diagnostics Product Portfolio
13.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
14 INDUSTRY CHAIN ANALYSIS
14.1 Tuberculosis (TB) Diagnostics Industry Chain Analysis
14.2 Tuberculosis (TB) Diagnostics Typical Downstream Customers
14.3 Tuberculosis (TB) Diagnostics Sales Channel Analysis
15 RESEARCH FINDINGS AND CONCLUSION
16 METHODOLOGY AND DATA SOURCE
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer
LIST OF TABLES
Table 1: Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type, 2024 VS 2025 VS 2032 (US$ Million)
Table 2: Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Application, 2024 VS 2025 VS 2032 (US$ Million)
Table 3: Tuberculosis (TB) Diagnostics Industry Development Status
Table 4: Tuberculosis (TB) Diagnostics Industry Development Trends
Table 5: Global Tuberculosis (TB) Diagnostics Market Size by Region in US$ Million: 2024 VS 2025 VS 2032
Table 6: Global Tuberculosis (TB) Diagnostics Revenue by Region (2020-2025) & (US$ Million)
Table 7: Global Tuberculosis (TB) Diagnostics Revenue Market Share by Region (2020-2025)
Table 8: Global Tuberculosis (TB) Diagnostics Revenue Forecast by Region (2026-2032) & (US$ Million)
Table 9: Global Tuberculosis (TB) Diagnostics Revenue Market Share Forecast by Region (2026-2032)
Table 10: Global Tuberculosis (TB) Diagnostics Revenue Analysis by Type (2020-2025) & (US$ Million)
Table 11: Global Tuberculosis (TB) Diagnostics Revenue Analysis Forecast by Type (2026-2032) & (US$ Million)
Table 12: Global Tuberculosis (TB) Diagnostics Revenue Analysis by Application (2020-2025) & (US$ Million)
Table 13: Global Tuberculosis (TB) Diagnostics Revenue Analysis Forecast by Application (2026-2032) & (US$ Million)
Table 14: Key Tuberculosis (TB) Diagnostics Players in North America
Table 15: North America Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 16: North America Tuberculosis (TB) Diagnostics Revenue by Type (2026-2032) & (US$ Million)
Table 17: North America Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 18: North America Tuberculosis (TB) Diagnostics Revenue by Application (2026-2032) & (US$ Million)
Table 19: North America Tuberculosis (TB) Diagnostics Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 20: North America Tuberculosis (TB) Diagnostics Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 21: Key Tuberculosis (TB) Diagnostics Players in Europe
Table 22: Europe Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 23: Europe Tuberculosis (TB) Diagnostics Revenue by Type (2026-2032) & (US$ Million)
Table 24: Europe Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 25: Europe Tuberculosis (TB) Diagnostics Revenue by Application (2026-2032) & (US$ Million)
Table 26: Europe Tuberculosis (TB) Diagnostics Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 27: Europe Tuberculosis (TB) Diagnostics Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 28: Key Tuberculosis (TB) Diagnostics Players in China
Table 29: China Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 30: China Tuberculosis (TB) Diagnostics Revenue by Type (2026-2032) & (US$ Million)
Table 31: China Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 32: China Tuberculosis (TB) Diagnostics Revenue by Application (2026-2032) & (US$ Million)
Table 33: Key Tuberculosis (TB) Diagnostics Players in APAC (excl. China)
Table 34: APAC (excl. China) Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 35: APAC (excl. China) Tuberculosis (TB) Diagnostics Revenue by Type (2026-2032) & (US$ Million)
Table 36: APAC (excl. China) Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 37: APAC (excl. China) Tuberculosis (TB) Diagnostics Revenue by Application (2026-2032) & (US$ Million)
Table 38: APAC (excl. China) Tuberculosis (TB) Diagnostics Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 39: APAC (excl. China) Tuberculosis (TB) Diagnostics Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 40: Key Tuberculosis (TB) Diagnostics Players in Latin America
Table 41: Latin America Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 42: Latin America Tuberculosis (TB) Diagnostics Revenue by Type (2026-2032) & (US$ Million)
Table 43: Latin America Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 44: Latin America Tuberculosis (TB) Diagnostics Revenue by Application (2026-2032) & (US$ Million)
Table 45: Latin America Tuberculosis (TB) Diagnostics Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 46: Latin America Tuberculosis (TB) Diagnostics Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 47: Key Tuberculosis (TB) Diagnostics Players in Middle East & Africa
Table 48: Middle East & Africa Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 49: Middle East & Africa Tuberculosis (TB) Diagnostics Revenue by Type (2026-2032) & (US$ Million)
Table 50: Middle East & Africa Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 51: Middle East & Africa Tuberculosis (TB) Diagnostics Revenue by Application (2026-2032) & (US$ Million)
Table 52: Middle East & Africa Tuberculosis (TB) Diagnostics Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 53: Middle East & Africa Tuberculosis (TB) Diagnostics Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 54: Global Tuberculosis (TB) Diagnostics Market Revenue by Key Suppliers (2021-2025) & (US$ Million)
Table 55: Global Tuberculosis (TB) Diagnostics Revenue Market Share by Key Suppliers (2021-2025)
Table 56: Global Key Suppliers Headquarter Location and Key Area Sales
Table 57: Market Mergers & Acquisitions, Expansion
Table 58: Danaher Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 59: Danaher Tuberculosis (TB) Diagnostics Product Portfolio
Table 60: Danaher Tuberculosis (TB) Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 61: Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 62: Roche Tuberculosis (TB) Diagnostics Product Portfolio
Table 63: Roche Tuberculosis (TB) Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 64: Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 65: Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Portfolio
Table 66: Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 67: BD Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 68: BD Tuberculosis (TB) Diagnostics Product Portfolio
Table 69: BD Tuberculosis (TB) Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 70: Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 71: Abbott Tuberculosis (TB) Diagnostics Product Portfolio
Table 72: Abbott Tuberculosis (TB) Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 73: Hologic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 74: Hologic Tuberculosis (TB) Diagnostics Product Portfolio
Table 75: Hologic Tuberculosis (TB) Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 76: Qiagen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 77: Qiagen Tuberculosis (TB) Diagnostics Product Portfolio
Table 78: Qiagen Tuberculosis (TB) Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 79: BioMerieux Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 80: BioMerieux Tuberculosis (TB) Diagnostics Product Portfolio
Table 81: BioMerieux Tuberculosis (TB) Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 82: Hain Lifescience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 83: Hain Lifescience Tuberculosis (TB) Diagnostics Product Portfolio
Table 84: Hain Lifescience Tuberculosis (TB) Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 85: Oxford Immunotec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 86: Oxford Immunotec Tuberculosis (TB) Diagnostics Product Portfolio
Table 87: Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 88: Tuberculosis (TB) Diagnostics Typical Customer List
Table 89: Tuberculosis (TB) Diagnostics Distributors List
Table 1: Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type, 2024 VS 2025 VS 2032 (US$ Million)
Table 2: Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Application, 2024 VS 2025 VS 2032 (US$ Million)
Table 3: Tuberculosis (TB) Diagnostics Industry Development Status
Table 4: Tuberculosis (TB) Diagnostics Industry Development Trends
Table 5: Global Tuberculosis (TB) Diagnostics Market Size by Region in US$ Million: 2024 VS 2025 VS 2032
Table 6: Global Tuberculosis (TB) Diagnostics Revenue by Region (2020-2025) & (US$ Million)
Table 7: Global Tuberculosis (TB) Diagnostics Revenue Market Share by Region (2020-2025)
Table 8: Global Tuberculosis (TB) Diagnostics Revenue Forecast by Region (2026-2032) & (US$ Million)
Table 9: Global Tuberculosis (TB) Diagnostics Revenue Market Share Forecast by Region (2026-2032)
Table 10: Global Tuberculosis (TB) Diagnostics Revenue Analysis by Type (2020-2025) & (US$ Million)
Table 11: Global Tuberculosis (TB) Diagnostics Revenue Analysis Forecast by Type (2026-2032) & (US$ Million)
Table 12: Global Tuberculosis (TB) Diagnostics Revenue Analysis by Application (2020-2025) & (US$ Million)
Table 13: Global Tuberculosis (TB) Diagnostics Revenue Analysis Forecast by Application (2026-2032) & (US$ Million)
Table 14: Key Tuberculosis (TB) Diagnostics Players in North America
Table 15: North America Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 16: North America Tuberculosis (TB) Diagnostics Revenue by Type (2026-2032) & (US$ Million)
Table 17: North America Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 18: North America Tuberculosis (TB) Diagnostics Revenue by Application (2026-2032) & (US$ Million)
Table 19: North America Tuberculosis (TB) Diagnostics Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 20: North America Tuberculosis (TB) Diagnostics Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 21: Key Tuberculosis (TB) Diagnostics Players in Europe
Table 22: Europe Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 23: Europe Tuberculosis (TB) Diagnostics Revenue by Type (2026-2032) & (US$ Million)
Table 24: Europe Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 25: Europe Tuberculosis (TB) Diagnostics Revenue by Application (2026-2032) & (US$ Million)
Table 26: Europe Tuberculosis (TB) Diagnostics Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 27: Europe Tuberculosis (TB) Diagnostics Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 28: Key Tuberculosis (TB) Diagnostics Players in China
Table 29: China Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 30: China Tuberculosis (TB) Diagnostics Revenue by Type (2026-2032) & (US$ Million)
Table 31: China Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 32: China Tuberculosis (TB) Diagnostics Revenue by Application (2026-2032) & (US$ Million)
Table 33: Key Tuberculosis (TB) Diagnostics Players in APAC (excl. China)
Table 34: APAC (excl. China) Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 35: APAC (excl. China) Tuberculosis (TB) Diagnostics Revenue by Type (2026-2032) & (US$ Million)
Table 36: APAC (excl. China) Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 37: APAC (excl. China) Tuberculosis (TB) Diagnostics Revenue by Application (2026-2032) & (US$ Million)
Table 38: APAC (excl. China) Tuberculosis (TB) Diagnostics Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 39: APAC (excl. China) Tuberculosis (TB) Diagnostics Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 40: Key Tuberculosis (TB) Diagnostics Players in Latin America
Table 41: Latin America Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 42: Latin America Tuberculosis (TB) Diagnostics Revenue by Type (2026-2032) & (US$ Million)
Table 43: Latin America Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 44: Latin America Tuberculosis (TB) Diagnostics Revenue by Application (2026-2032) & (US$ Million)
Table 45: Latin America Tuberculosis (TB) Diagnostics Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 46: Latin America Tuberculosis (TB) Diagnostics Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 47: Key Tuberculosis (TB) Diagnostics Players in Middle East & Africa
Table 48: Middle East & Africa Tuberculosis (TB) Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 49: Middle East & Africa Tuberculosis (TB) Diagnostics Revenue by Type (2026-2032) & (US$ Million)
Table 50: Middle East & Africa Tuberculosis (TB) Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 51: Middle East & Africa Tuberculosis (TB) Diagnostics Revenue by Application (2026-2032) & (US$ Million)
Table 52: Middle East & Africa Tuberculosis (TB) Diagnostics Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 53: Middle East & Africa Tuberculosis (TB) Diagnostics Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 54: Global Tuberculosis (TB) Diagnostics Market Revenue by Key Suppliers (2021-2025) & (US$ Million)
Table 55: Global Tuberculosis (TB) Diagnostics Revenue Market Share by Key Suppliers (2021-2025)
Table 56: Global Key Suppliers Headquarter Location and Key Area Sales
Table 57: Market Mergers & Acquisitions, Expansion
Table 58: Danaher Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 59: Danaher Tuberculosis (TB) Diagnostics Product Portfolio
Table 60: Danaher Tuberculosis (TB) Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 61: Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 62: Roche Tuberculosis (TB) Diagnostics Product Portfolio
Table 63: Roche Tuberculosis (TB) Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 64: Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 65: Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Portfolio
Table 66: Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 67: BD Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 68: BD Tuberculosis (TB) Diagnostics Product Portfolio
Table 69: BD Tuberculosis (TB) Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 70: Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 71: Abbott Tuberculosis (TB) Diagnostics Product Portfolio
Table 72: Abbott Tuberculosis (TB) Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 73: Hologic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 74: Hologic Tuberculosis (TB) Diagnostics Product Portfolio
Table 75: Hologic Tuberculosis (TB) Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 76: Qiagen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 77: Qiagen Tuberculosis (TB) Diagnostics Product Portfolio
Table 78: Qiagen Tuberculosis (TB) Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 79: BioMerieux Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 80: BioMerieux Tuberculosis (TB) Diagnostics Product Portfolio
Table 81: BioMerieux Tuberculosis (TB) Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 82: Hain Lifescience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 83: Hain Lifescience Tuberculosis (TB) Diagnostics Product Portfolio
Table 84: Hain Lifescience Tuberculosis (TB) Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 85: Oxford Immunotec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 86: Oxford Immunotec Tuberculosis (TB) Diagnostics Product Portfolio
Table 87: Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 88: Tuberculosis (TB) Diagnostics Typical Customer List
Table 89: Tuberculosis (TB) Diagnostics Distributors List
LIST OF FIGURES
Figure 1: Tuberculosis (TB) Diagnostics Product Pictures
Figure 2: Culture-Based Diagnostics Picture Scope
Figure 3: Sputum Smear Microscopy Picture Scope
Figure 4: Rapid Molecular Diagnostics Picture Scope
Figure 5: Others Picture Scope
Figure 6: Diagnostic Laboratories Picture Scope
Figure 7: Hospitals Picture Scope
Figure 8: Global Tuberculosis (TB) Diagnostics Market Size Analysis: 2024 VS 2025 VS 2032 (US$ Million)
Figure 9: Global Tuberculosis (TB) Diagnostics Market Revenue and Growth Rate Analysis: (2020-2032) & (US$ Million)
Figure 10: Global Tuberculosis (TB) Diagnostics Market Size by Region (2020-2032) & (US$ Million)
Figure 11: Global Tuberculosis (TB) Diagnostics Market Share Scenario by Region in Percentage: 2025 Versus 2032
Figure 12: North America Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 13: North America Tuberculosis (TB) Diagnostics Market Share by Players in 2024
Figure 14: North America Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2032)
Figure 15: North America Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2032)
Figure 16: US Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 17: Canada Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 18: Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 19: Europe Tuberculosis (TB) Diagnostics Market Share by Players in 2024
Figure 20: Europe Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2032)
Figure 21: Europe Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2032)
Figure 22: Germany Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 23: France Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 24: United Kingdom Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 25: Italy Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 26: Spain Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 27: Benelux Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 28: China Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 29: China Tuberculosis (TB) Diagnostics Market Share by Players in 2024
Figure 30: China Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2032)
Figure 31: China Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2032)
Figure 32: APAC (excl. China) Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 33: APAC (excl. China) Tuberculosis (TB) Diagnostics Market Share by Players in 2024
Figure 34: APAC (excl. China) Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2032)
Figure 35: APAC (excl. China) Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2032)
Figure 36: Japan Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 37: South Korea Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 38: India Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 39: Australia Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 40: Southeast Asia Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 41: Latin America Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 42: Latin America Tuberculosis (TB) Diagnostics Market Share by Players in 2024
Figure 43: Latin America Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2032)
Figure 44: Latin America Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2032)
Figure 45: Mexico Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 46: Brazil Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 47: Middle East & Africa Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 48: Middle East & Africa Tuberculosis (TB) Diagnostics Market Share by Players in 2024
Figure 49: Middle East & Africa Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2032)
Figure 50: Middle East & Africa Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2032)
Figure 51: Saudi Arabia Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 52: South Africa Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 53: Global Tuberculosis (TB) Diagnostics Revenue Market Share by Key Suppliers in 2024
Figure 54: Global Tuberculosis (TB) Diagnostics Industry Competition Landscape
Figure 55: Tuberculosis (TB) Diagnostics Industry Chain Analysis
Figure 56: Bottom-Up and Top-Down Research Methods
Figure 57: Key Interview Objectives
Figure 58: Data Cross Validation
Figure 1: Tuberculosis (TB) Diagnostics Product Pictures
Figure 2: Culture-Based Diagnostics Picture Scope
Figure 3: Sputum Smear Microscopy Picture Scope
Figure 4: Rapid Molecular Diagnostics Picture Scope
Figure 5: Others Picture Scope
Figure 6: Diagnostic Laboratories Picture Scope
Figure 7: Hospitals Picture Scope
Figure 8: Global Tuberculosis (TB) Diagnostics Market Size Analysis: 2024 VS 2025 VS 2032 (US$ Million)
Figure 9: Global Tuberculosis (TB) Diagnostics Market Revenue and Growth Rate Analysis: (2020-2032) & (US$ Million)
Figure 10: Global Tuberculosis (TB) Diagnostics Market Size by Region (2020-2032) & (US$ Million)
Figure 11: Global Tuberculosis (TB) Diagnostics Market Share Scenario by Region in Percentage: 2025 Versus 2032
Figure 12: North America Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 13: North America Tuberculosis (TB) Diagnostics Market Share by Players in 2024
Figure 14: North America Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2032)
Figure 15: North America Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2032)
Figure 16: US Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 17: Canada Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 18: Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 19: Europe Tuberculosis (TB) Diagnostics Market Share by Players in 2024
Figure 20: Europe Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2032)
Figure 21: Europe Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2032)
Figure 22: Germany Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 23: France Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 24: United Kingdom Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 25: Italy Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 26: Spain Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 27: Benelux Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 28: China Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 29: China Tuberculosis (TB) Diagnostics Market Share by Players in 2024
Figure 30: China Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2032)
Figure 31: China Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2032)
Figure 32: APAC (excl. China) Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 33: APAC (excl. China) Tuberculosis (TB) Diagnostics Market Share by Players in 2024
Figure 34: APAC (excl. China) Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2032)
Figure 35: APAC (excl. China) Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2032)
Figure 36: Japan Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 37: South Korea Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 38: India Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 39: Australia Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 40: Southeast Asia Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 41: Latin America Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 42: Latin America Tuberculosis (TB) Diagnostics Market Share by Players in 2024
Figure 43: Latin America Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2032)
Figure 44: Latin America Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2032)
Figure 45: Mexico Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 46: Brazil Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 47: Middle East & Africa Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 48: Middle East & Africa Tuberculosis (TB) Diagnostics Market Share by Players in 2024
Figure 49: Middle East & Africa Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2032)
Figure 50: Middle East & Africa Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2032)
Figure 51: Saudi Arabia Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 52: South Africa Tuberculosis (TB) Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 53: Global Tuberculosis (TB) Diagnostics Revenue Market Share by Key Suppliers in 2024
Figure 54: Global Tuberculosis (TB) Diagnostics Industry Competition Landscape
Figure 55: Tuberculosis (TB) Diagnostics Industry Chain Analysis
Figure 56: Bottom-Up and Top-Down Research Methods
Figure 57: Key Interview Objectives
Figure 58: Data Cross Validation
